Esperion to Participate in Upcoming Virtual Cowen 42nd Annual Healthcare Conference
February 24 2022 - 8:00AM
Esperion (NASDAQ: ESPR) today announced that Chief Medical Officer,
Dr. JoAnne Foody, will participate in a Cardiometabolic/NASH
focused panel, in addition to one-on-one investor meetings with
other members of management, at the upcoming Cowen 42nd Annual
Healthcare Conference on Tuesday, March 8, 2022.
Event: |
Cowen 42nd
Annual Healthcare Conference |
Date: |
Tuesday, March 8, 2022 |
Format: |
Virtual Panel and 1:1 Meetings |
Panel: |
Cardiometabolic/NASH |
Time: |
12:50 p.m. ET |
Live audio webcasts of these events can be accessed on the
investor relations section of the Esperion website at
www.esperion.com/investors-media/events-presentations/. Replays of
the webcasts will be archived on the Company's website for 90 days
following the events.
Esperion Therapeutics
Esperion is The Lipid Management Company. Our goal is lipid
management for everybody, that’s why we work hard to make our
medicines easy to get, easy to take and easy to have. We discover,
develop and commercialize innovative medicines and combinations to
lower cholesterol, especially for patients whose needs aren’t being
met by the status quo. Our entrepreneurial team of industry leaders
is inclusive, passionate and resourceful. For more information,
please visit www.esperion.com and follow us on Twitter at
www.twitter.com/EsperionInc.
Investor Contact:Kaitlyn
BroscoEsperioncorporateteam@esperion.com
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jun 2024 to Jul 2024
Esperion Therapeutics (NASDAQ:ESPR)
Historical Stock Chart
From Jul 2023 to Jul 2024